ALXO
ALX Oncology Holdings Inc.
Company Overview
| Mkt Cap | $82.47M | Price | $1.54 |
| Volume | 99.87K | Change | -0.65% |
| P/E Ratio | -0.6 | Open | $1.52 |
| Revenue | -- | Prev Close | $1.55 |
| Net Income | $-134.8M | 52W Range | $0.40 - $2.27 |
| Div Yield | N/A | Target | $2.25 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 40 |
No chart data available
Stock Overview
Updated DailyALX Oncology Holdings Inc. (ALXO) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $1.54 with a market capitalization of $82.47 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ALXO with a volume of 100K shares. The stock opened down 1.94% from yesterday's close of $1.55. Current analyst estimates project earnings of $-1.74 per share for this year, with next year targeting $-1.06.
ALXO demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ALXO include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 46.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 07:46 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALXO | $1.54 | -0.6% | 99.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ALX Oncology Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW